Patient characteristics and early experiences with anti-obesity medications: the CAMP study. (PubMed, Front Nutr) - Sep 24, 2026 - "Financial barriers were the main reasons for treatment discontinuation, and potentially important referrals to nutrition and behavioral services were infrequent. These findings provide important real-world insights into the implementation of anti-obesity pharmacotherapy and identify leverage points for improving access, continued use, and multidisciplinary obesity treatment."
Journal • Genetic Disorders • Obesity
|
|
Colleen Tewksbury; Emma Adelia Soliva; Karen Glanz; Krista Scheffey; Pui Lui Kwong
|